Naslov
Is the long-term thyroxine treatment risk for bone mass loss?

Autori
Karner, Ivan ; Šijanović, Siniša ; Cvijetić, Selma

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Abstract book of the Third international congress of the Croatian society of Nuclear medicine / Dodig, Damir ; Božidar, Kasal - Zagreb : Hrvatski liječnički zbor, 1999, 12-12

Skup
Third international congress of the Croatian Society of Nuclear medicine

Mjesto i datum
Opatija, Hrvatska, 10.05.1999. - 12.05.1999

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
bone densitometry; thyroxine suppressive therapy; bone loss

Sažetak
In this prospective study, the effect of suppressive therapy with levothyroxine after total surgical thyreoidectomy for diferentiated thyroid carcinoma was investigated. There were 17 premenopausal women with regular menstruations, and 11 men, aged less than 50 years. None of the patients had bone metastases or other distal organs. Bone mineral density was measured on two occasions during a four-year period. A DPX operating on principle of dual-energy X-ray absorptiometry, was used for the measurement of the lumbar spine and the femoral neck bone mineral content. Mineral density in the lower third of the forearm was determined on a Lunar SP2, operating on the principle of single-photon absorptiometry. Bone loss was found in 10 women and 4 male subjects. Long-term suppressive thyroxine therapy is associated with the risk of bone mass loss in some patients.

Izvorni jezik
Engleski

POVEZANOST RADA